Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit ...

Teva collaboration agreement aims to accelerate clinical data generation for TEV-56278 and develop Anti-PD1-IL2 Therapy.

Ecolab has launched a new resin designed to help achieve cost savings and optimize operations throughout the antibody ...

How can early decisions in cell and gene therapy clinical development impact downstream progress toward commercialization and ...

Looking at key trends in outsourcing, manufacturing, and regulatory compliance. Embracing innovation, flexibility, and talent ...

How specialized expertise, advanced infrastructure, and strategic partnerships are enabling the next generation of cell-based ...

Advanced technologies and close collaboration maximize yields, safety, and patient access to life-saving therapies.